VASO CORPORATION

VASO ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $89.1M $86.8M $81.0M $79.3M $75.6M $69.9M $75.5M $74.0M
Cost of Revenue $34.4M $34.7M $30.4M $31.4M $32.4M $31.3M $33.1M $32.9M
Gross Profit $54.7M $52.1M $50.6M $47.9M $43.1M $38.6M $42.4M $41.1M
Gross Margin 61.4% 60.0% 62.4% 60.4% 57.1% 55.2% 56.2% 55.6%
Operating Expenses
Research & Development $728.0K $851.0K $755.0K $605.0K $1.7M $745.0K $813.0K $886.0K
SG&A Expense $52.2M $49.0M $45.1M $40.8M $38.6M $37.1M $41.0M $44.0M
Operating Income $-2.9M $285.0K $4.2M $6.5M $2.8M $772.0K $591.0K $-3.7M
Operating Margin -3.2% 0.3% 5.2% 8.1% 3.7% 1.1% 0.8% -5.0%
Interest Expense
Pretax Income $-1.3M $1.3M $4.9M $6.6M $6.3M $357.0K $-271.0K $-4.1M
Income Tax Expense $-2.9M $326.0K $100.0K $-4.7M $151.0K $1.0K $111.0K $-385.0K
Net Income $1.6M $951.0K $4.8M $11.3M $6.1M $358.0K $-382.0K $-3.7M
Net Margin 1.8% 1.1% 5.9% 14.2% 8.1% 0.5% -0.5% -5.0%
EPS (Basic) $0.01 $0.01 $0.03 $0.07 $0.04 $0.00 $0.00 $0.00
EPS (Diluted) $0.01 $0.01 $0.03 $0.06 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 175.8M 175.4M 174.4M 173.1M 171.7K 172.8M 170.7M 168.2M
Shares Outstanding (Diluted) 176.0M 175.6M 175.5M 174.7M 173.8M 173.8M 170.7M 168.2M
Dividends Per Share
← Newer Page 1 of 2 Older →